Stock Analiz

Abivax S.A. (ABVX) financials: revenue, earnings and cash flow

Fiscal 2021–2025 · from SEC filings · data as of November 13, 2026

Summary

Abivax’s revenue went from $14M in fiscal 2021 to $5M in fiscal 2025, a decline of about 20.7% a year.

Net income in fiscal 2025 was -$395M, a net margin of -7354.5%; the best year in this period was 2021 with -$48M.

Free cash flow was -$189M in fiscal 2025 and positive in 0 of the 5 years shown.

Revenue, profit and cash flow by year

Revenue
2021: $14M20212022: $5M20222023: $5M20232024: $13M20242025: $5M2025$5M
Net income
2021: -$48M20212022: -$65M20222023: -$163M20232024: -$183M20242025: -$395M2025-$395M
Free cash flow
2021: -$51M20212022: -$58M20222023: -$108M20232024: -$161M20242025: -$189M2025-$189M
EPS (diluted)
2021: $-0.5520212022: $-0.7420222023: $-1.8720232024: $-2.1020242025: $-4.532025$-4.53

Income statement

Fiscal year20252024202320222021
Revenue$5M$13M$5M$5M$14M
Gross profit—————
Operating income-$289M-$180M-$141M-$69M-$47M
Net income-$395M-$183M-$163M-$65M-$48M
EPS (diluted)$-4.53$-2.10$-1.87$-0.74$-0.55
R&D—————
Revenue growth−58.5%+153.3%+4.5%−63.9%—

Cash flow

Fiscal year20252024202320222021
Operating cash flow-$189M-$160M-$107M-$58M-$51M
Capital spending-$166851-$664894-$292824-$307180-$53232
Free cash flow-$189M-$161M-$108M-$58M-$51M
Dividends paid$0$0$0$0$0
Buybacks—————
Stock-based pay$42M$21M$9M-$1M$937797

Balance sheet

Fiscal year20252024202320222021
Cash$607M$150M$278M$29M$69M
Debt$0$0$0$0$0
Equity$535M$42M$217M$8M$29M
Total assets$687M$213M$361M$81M$124M
Shares (diluted)87M87M87M87M87M

Margins and returns

Fiscal year20252024202320222021
Gross margin—————
Operating margin-5384.2%-1389.5%-2756.5%-1414.7%-346.1%
Net margin-7354.5%-1415.7%-3197.1%-1325.3%-354.9%
FCF margin-3528.9%-1242.8%-2107.7%-1183.2%-377.0%
ROIC-42.7%-426.2%-65.0%-901.9%-159.6%
ROE-73.8%-434.3%-75.4%-844.9%-163.7%

Frequently asked questions

What is Abivax’s annual revenue?

$5M in fiscal 2025.

How much profit does Abivax make?

Net income was -$395M in fiscal 2025 (net margin -7354.5%).

Is Abivax’s revenue growing?

No: revenue fell 58.5% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.